Our Monthly Scientific Selection: July Publications on EuroQol Instruments #7

[1-31 July 2024]

1. Bailey H, Jonker MF, Pullenayegum E, Rencz F, Roudijk B. The EQ-5D-5L valuation study for Trinidad and Tobago. Health Qual Life Outcomes. 2024 Jul 2.

2. Jonker MF, Roudijk B. A new and improved experimental design for the discrete choice experiment module of the EQ-VT valuation protocol. Value Health. 2024 Jul 6.

3. Yang Z, Rand K, Luo N. Valuation of multi-dimensional health states with a “bolt-on”: is there a shortcut? Value Health. 2024 Jul 6.

4. Yao Q, Yang F, Zhang X, Qi J, Li H, Wu Y, Liu C. EQ-5D-5L Population Scores in Mainland China: Results From a Nationally Representative Survey 2021. Value Health. 2024 Jul 6.

5. Powell PA, Rowen D, Keetharuth A, Mukuria C, Shah K. Who should value children’s health and how? An international Delphi study. Soc Sci Med. 2024 Jul 11.

6. Jumamyradov M, Craig BM, Jakubczyk M. Scale and rate heterogeneity in the EQ-5D-5L valuation. Health Qual Life Outcomes. 2024 Jul 13.

7. Belay YB, Mihalopoulos C, Lee YY, Engel L. Health-related quality of life and utility values among patients with anxiety and/or depression in a low-income tertiary care setting: a cross-sectional analysis. Qual Life Res. 2024 Jul 16.

8. Zhou W, Li Y, Busschbach J, Herdman M, Yang Z, Lu Y. Psychometric validation of the Chinese versions of EQ-5D-Y-3L and the experimental EQ-TIPS in children and adolescents with COVID-19. Eur J Health Econ. 2024 Jul 27.

9. Jie Cheng L, Ann Chen L, Ying Cheng J, Herdman M, Luo N. Systematic review reveals that EQ-5D minimally important differences decrease with increasing baseline score and may vary with treatment type. J Clin Epidemiol. 2024 Jul 29.

10. Chua AP, Janssen MF, Cheng LJ, Busschbach J, Luo N. An Exploratory Study of Alternative Timeframes and Descriptors for EQ-5D-5L in Obstructive Airway Diseases Using Mixed Methods. Value Health. 2024 Jul 31.